BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1643360)

  • 1. [Oxyprogesterone capronate in the treatment of menstrual epilepsy].
    Badalian LO; Temin PA; Mukhin KIu
    Ross Med Zh; 1992; (3):41-4. PubMed ID: 1643360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of 17-alpha-hydroxprogesterone-capronate in certain malignant tumors].
    Garin AM; Voznyĭ EK; Borisov VI; Dobrushina VA; Lazovskaia EB
    Klin Med (Mosk); 1974 Mar; 52(3):121-3. PubMed ID: 4466932
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal therapy of cancer of the corpus uteri].
    Nigaĭ SV; Smakhtina OL; Kozbagarova RG; Nigmatullina AA
    Vopr Onkol; 1983; 29(3):22-6. PubMed ID: 6836982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lutenyl and menstrual disorders. A hospital study].
    Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine disorders in epilepsy and their hormonal correction].
    Badalian LO; Temin PA; Mukhin Kiu ; Semenov PA
    Sov Med; 1989; (10):49-51. PubMed ID: 2694382
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of hormone therapy in the treatment of cancer of the endometrium].
    Vekhova LI; Shuvaeva NI; Malysheva SF; Lebedeva AV
    Vopr Onkol; 1983; 29(3):26-30. PubMed ID: 6836983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of juvenile uterine hemorrhages with synthetic progestins].
    Antipina NN
    Vopr Okhr Materin Det; 1975 Jul; 20(7):70-3. PubMed ID: 1220184
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of patients with dysfunctional uterine hemorrhages with different types of synthetic progestins].
    Sotnikova EI
    Sov Med; 1975 Jun; (6):31-5. PubMed ID: 1162470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in the cytodiagnosis of hyperestrin menstruation disorders and their therapy].
    Kobilková J; Málek J
    Cesk Gynekol; 1966 Feb; 31(1):34-8. PubMed ID: 5930099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience in the treatment of menstruation disorders with Superlutin].
    Horák C; Sedliak M
    Cesk Gynekol; 1966 Feb; 31(1):86-8. PubMed ID: 5932092
    [No Abstract]   [Full Text] [Related]  

  • 11. 21-year-old woman with menstrual irregularity, 1 year later.
    Daley J; Delbanco TL; Hartman EE
    JAMA; 1997 Nov; 278(20):1699. PubMed ID: 9388091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dydrogesterone in the regulation of cycle disturbances in adolescence].
    Chomczyk I; Sipowicz M; Sipowicz I
    Ginekol Pol; 1999 May; 70(5):343-7. PubMed ID: 10462978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of side effects of synthetic progestins with different content of estrogenic and gestagenic components].
    Rotkina IE; Lutsik LA; Dubovik NT
    Akush Ginekol (Mosk); 1977 Sep; (9):29-31. PubMed ID: 596558
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of total regression of endometrial carcinoma metastases in the lung under hormonal therapy (author's transl)].
    Caminati M; Hauser GA
    Ther Umsch; 1979 Jun; 36(6):516-7. PubMed ID: 462406
    [No Abstract]   [Full Text] [Related]  

  • 17. [The efficacy of dydrogesterone in the treatment of menstrual cycle disorders in girls].
    Sipowicz I; Chomczyk I
    Ginekol Pol; 1998 Oct; 69(10):767-70. PubMed ID: 9884472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of nomegestrol acetate in the treatment of menstruation disorders. Our experience in 56 cases].
    Persiani P; Radici E; Lombardi PA; Lombardi PL
    Minerva Ginecol; 1997 Apr; 49(4):181-5. PubMed ID: 9206771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methyl-hydroxyprogesterone acetate in association with ethinyl estradiol in obstetrics and gynecology].
    Avezzù G; Vinci GW
    Quad Clin Ostet Ginecol; 1966 Jan; 21(1):23-39. PubMed ID: 5959285
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiologic substitution of estrogens and progesterones].
    Presl J
    Cesk Gynekol; 1987 Jul; 52(6):461-7. PubMed ID: 3664658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.